Tablets will lead sodium dichloroisocyanurate sales through 2036 with a 44.0% share of the form segment in 2026. The market was valued at USD 649.49 million in 2025 and is expected to reach USD 1,631.44 million by 2036, creating an incremental opportunity of USD 786.44 million between 2026 and 2036.